期刊文献+

血清中miRNA常用提取方法的综合比较 被引量:3

Comparison of current laboratory used of miRNA extraction
下载PDF
导出
摘要 目的:对目前实验室常用的4种miRNA提取方法的比较,探讨其临床实用性。方法:使用各自的说明书进行提取miRNA,检测目前血液中公认含量比较高的miRNA--U6,通过RT和Q-PCR后的CT值,进行含量和稳定性比较。结果:miRNeasy Mini Kit-TRIzol的CT值较小,稳定性也较好。结论:各种提取方法有显著差异,但是差异较小,miRNeasy Mini KitTRIzol法相对而言较好。 Objective:Comparison of current laboratory used four kinds of miRNA extraction, to explore its clinical utility. Methods: Respective manual extraction of miRNA to detect the relatively high content of blood recognized the miRNA - U6 RT and Q-PCR CT value, content and stability. Resuhs:CT value of miRNeasy Mini KitTRIzol is the best, mirVana PARIS kit have a good stability. Conclusion:Significant differences in the various extraction methods, but the difference is smaller,and the miRNeasy Mini KitTRIzol relatively better.
作者 徐翔 贺丽卉
出处 《北方药学》 2012年第7期31-32,共2页 Journal of North Pharmacy
关键词 MIRNA 提取 Q-PCR :miRNA Extraction Q-PCR
  • 相关文献

参考文献5

  • 1Du T,Zamore PD.microPrimer:the biogenesisand function of microRNA Development[J].2005,132 : 4645--4652.
  • 2Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA, targets [J].Cell,2003,115: 787-798.
  • 3Volinia S, Calin GA, Liu CG, et al.A microRNA expressionsignature of human solid tumors define cancer gene targets[J].Proc.Nafl Acad. Sci USA, 2006,103 (7) : 2257-2261.
  • 4Lu J,Getz G,Miska EA,et al.MicroRNA expression profilesclassify human cancers[J].Nature, 2005,435(7043 ): 834--838,.
  • 5Xi Chen,Yi Ba,Lijia Ma,Xing Cai,Yuan Yin,Kehui Wang,Jig ang Guo,Yujing Zhang,Jiangning Chen,Xing Guo,Qibin Li,Xiaoying Li,Wenjing Wang,Yan Zhang,Jin Wang,Xueyuan Jiang,Yang Xiang,Chen Xu,Pingping Zheng,Juanbin Zhang,Ruiqiang Li,Hongjie Zhang,Xiaobin Shang,Ting Gong,Guang Ning,Jun Wang,Ke Zen,Junfeng Zhang,Chen-Yu Zhang.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J].Cell Research,2008,18(10):997-1006. 被引量:983

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献982

同被引文献30

  • 1黄凤兰,李长海,孙婷婷,高秀琴,胡宝忠.芍药花瓣总RNA的提取[J].生物技术通讯,2005,16(3):282-283. 被引量:17
  • 2李春喜,邵云,姜丽娜.生物统计学[M].北京:科学出版社,2008:239-245.
  • 3Jarry J, Schadendorf D, Greenwood C, et al. The validity of circulating microRNAs in oncology: five years of challenges and contradic- tions[J]. Mol Oncol,2014,8(4) :819-829.
  • 4Wu C, Wang C, Guan X, et al. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma [J]. PIoS One, 2014,9(3), e92292.
  • 5Page K, Guttery D S, Zahra N, et al. Influence of plasma processing on recovery and analysis of circulating nucleic acids[J]. PloS One, 2013,8(10) : e77963.
  • 6Takeshita N, Hoshino I, Mori M, et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma[J]. Br J Cancer,2013,108(3) :644-652.
  • 7Zhang T, Wang Q, Zhao D, et al. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcino- ma[J]. Clin Sci, 2011,121 (10) : 437-447.
  • 8Wu C, Li M, Hu C, et al. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carci- noma[J]. Mol Biol Rep,2014,41(3) :1257-1266.
  • 9Zhang C, Wang C, Chen X, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma[J]. Clin Chem, 2010,56(12) : 1871-1879.
  • 10Cai E H, Gao Y X, Wei Z Z, et al. Serum miR-21 expression in human esophageal squamous cell carcinomas [J]. Asian Pac J Cancer Prey,2012,13(4) :1563-1567.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部